Narrow search
Showing 1 - 10 of 34
Cover Image
Lifetime direct healthcare costs of treating colorectal cancer : a systematic review
Bhimani, Nazim; Wong, Geoffrey YM; Molloy, Charles; … - In: The European journal of health economics 24 (2023) 4, pp. 513-537
Persistent link: https://www.econbiz.de/10014328036
Cover Image
The economic burden of idiopathic pulmonary fibrosis in Australia : a cost of illness study
Cox, Ingrid A.; De Graaff, Barbara; Ahmed, Hasnat; … - In: The European journal of health economics 24 (2023) 7, pp. 1121-1139
Persistent link: https://www.econbiz.de/10014328174
Cover Image
Excess costs of multiple sclerosis : a register-based study in Sweden
Murley, Chantelle; Tinghög, Petter; Teni, Fitsum Sebsibe; … - In: The European journal of health economics 24 (2023) 8, pp. 1357-1371
Persistent link: https://www.econbiz.de/10014427238
Cover Image
A cost-effectiveness analysis of pembrolizumab with or without chemotherapy for the treatment of patients with metastatic, non-squamous non-small cell lung cancer and high PD-L1 ex...
Barbier, Michaela Carla; Pardo, Esther; Panje, Cédric … - In: The European journal of health economics 22 (2021) 5, pp. 669-677
Persistent link: https://www.econbiz.de/10012586580
Cover Image
Health-economic evaluation of collaborative orthogeriatric care for patients with a hip fracture in Germany : a retrospective cohort study using health and long-term care insurance...
Konnopka, Claudia; Büchele, Gisela; Peter, Raphael Simon; … - In: The European journal of health economics 22 (2021) 6, pp. 873-885
Persistent link: https://www.econbiz.de/10012586698
Cover Image
Economic evidence with respect to cost-effectiveness of the transitional care model among geriatric patients discharged from hospital to home : a systematic review
Kast, Kristina; Wachter, Carl-Philipp; Schöffski, Oliver; … - In: The European journal of health economics 22 (2021) 6, pp. 961-975
Persistent link: https://www.econbiz.de/10012586735
Cover Image
Cost-effectiveness evidence on approved cancer drugs in Ireland : the limits of data availability and implications for public accountability
Almajed, Suaad; Alotaibi, Nora; Zulfiqar, Sana; … - In: The European journal of health economics 23 (2022) 3, pp. 375-431
Persistent link: https://www.econbiz.de/10013198062
Cover Image
Cost-effectiveness analysis of vaborem for the treatment of carbapenem-resistant Enterobacteriaceae-Klebsiella pneumoniae carbapenemase (CRE-KPC) infections in the UK
Vlachaki, Ioanna; Zinzi, Daniela; Falla, Edel; … - In: The European journal of health economics 23 (2022) 3, pp. 537-549
Persistent link: https://www.econbiz.de/10013198220
Cover Image
Cost-utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland
Bommer, Claudine; Lupatsch, Judith; Bürki, Nicole; … - In: The European journal of health economics 23 (2022) 5, pp. 807-821
Persistent link: https://www.econbiz.de/10013279303
Cover Image
Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland
Barbier, Michaela; Durno, Nicholas; Bennison, Craig; … - In: The European journal of health economics 23 (2022) 5, pp. 837-846
Persistent link: https://www.econbiz.de/10013279318